Search Results 771-780 of 24337 for B cell lymphomas
The purpose of this study is to evaluate the long-term safety and effectiveness of zanubrutinib in participants with B-cell malignancies who were previously ...
Thompson has been awarded several research grants and has published numerous peer-reviewed articles. Conditions treated · B-cell lymphoma · Burkitt lymphoma ...
... B-cell lymphoma (DLBCL) that has come back or did not respond to previous treatment in patients who cannot receive a stem cell transplant. This medicine is ...
... B-cell lymphoma 2 (BCL2) inhibitor. Tissue and Blood Registry for Individuals with Liver and Biliary Tumors. Jacksonville, Fla. This study will collect and ...
D. Radiation Oncology Medical Physicist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Breast cancer, Cutaneous t-cell lymphoma, Prostate cancer, Eye ...
... cell engagers, and cellular therapy. He is part of the bone marrow ... B-cell lymphoma · Chronic lymphocytic leukemia · Follicular lymphoma · Hairy cell ...
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
... B-cell lymphoma. The study will consist of a dose-escalation stage and an ... Histologically documented B-cell lymphoma expected to express CD20 who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!